AIM: To explore the effects of hydrogen sulfide (H2S) on the myocardial fibrosis in a rat model of diabetes and its mechanism.METHODS: Single intraperitoneal injection of streptozotocin (STZ) was utilized to establish a rat model of diabetes. Sodium hydrosulfide was used as an exogenous donor of hydrogen sulfide. Male SD rats were randomly divided into control group, STZ group, STZ+H2S group and H2S group. Eight weeks later, HE and VG staining methods were used to observe the collagen distribution and collagen volume fraction was measured by image analysis. The expression levels of type I collagen, PPARγ and NF-κB in the cardiac tissues were determined by Western blotting.RESULTS: Compared with control group, collagen distribution and the expression levels of type I collagen and NF-κB in the cardiac tissues were markedly increased (P<0.05), while PPARγ was significantly decreased in STZ group (P<0.05), but these indexes were reversed significantly in STZ+H2S group (P<0.05). The expression levels of type I collagen, PPARγ and NF-κB had no significant difference between H2S group and control group.CONCLUSION: Hydrogen sulfide attenuates cardiac fibrosis in diabetic rats, and its mechanism may be related to PPARγ-NF-κB signaling pathway.
肖婷, 罗健, 吴志雄, 李芳, 张晶晶, 杨军. 硫化氢对糖尿病大鼠心肌纤维化及PPARγ、NF-κB表达的影响[J]. 中国病理生理杂志, 2015, 31(4): 635-639.
XIAO Ting, LUO Jian, WU Zhi-xiong, LI Fang, ZHANG Jing-jing, YANG Jun. Effect of hydrogen sulfide on myocardial fibrosis and PPARγ and NF-κB expression in rat model of diabetes. Chin J Pathophysiol, 2015, 31(4): 635-639.
Delerive P, Gervois P, Fruchart JC, et al. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators[J]. J Biol Chem, 2000, 275(47):36703-36707.
Song Y, Wang J, Li Y, et al. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury[J]. Am J Pathol, 2005, 167(1):17-26.
[5]
Burrell LM, Johnston CI, Tikellis C, et al. ACE2, a new regulator of the renin-angiotensin system[J]. Trends Endocrinol Metab, 2004, 15(4):166-169.